[
  {
    "ts": null,
    "headline": "Bristol Myers (BMY) Partners with Bain Capital to Create Immunology Therapies",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the top stocks sold by hedge funds. On July 28, Bristol Myers, in partnership with private equity firm Bain Capital, is poised to launch a standalone entity focused on advancing immunology drug development, with a $300 million financing commitment from Bain. The newly established company will focus on […]",
    "url": "https://finnhub.io/api/news?id=8b5867ba3793c91af1bf980958079a3426f2987f5a3b2b841350ce25e62f198b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755415128,
      "headline": "Bristol Myers (BMY) Partners with Bain Capital to Create Immunology Therapies",
      "id": 136408830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the top stocks sold by hedge funds. On July 28, Bristol Myers, in partnership with private equity firm Bain Capital, is poised to launch a standalone entity focused on advancing immunology drug development, with a $300 million financing commitment from Bain. The newly established company will focus on […]",
      "url": "https://finnhub.io/api/news?id=8b5867ba3793c91af1bf980958079a3426f2987f5a3b2b841350ce25e62f198b"
    }
  }
]